NCT07456202

Brief Summary

This prospective observational cohort study aims to evaluate the association between menstrual phase (determined by postoperative serum progesterone levels), intraoperative anesthetic consumption, and the incidence and severity of postoperative nausea and vomiting (PONV) in female patients undergoing cholecystectomy. Intraoperative anesthetic requirements will be recorded, and postoperative nausea and vomiting will be assessed using standardized scoring systems.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 28, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 6, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

March 7, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 27, 2026

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2026

Completed
Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

3 months

First QC Date

February 28, 2026

Last Update Submit

April 25, 2026

Conditions

Keywords

Anesthetic ConsumptionLuteal PhaseFollicular PhasePostoperative Nausea and Vomiting

Outcome Measures

Primary Outcomes (1)

  • Intraoperative Anesthetic Agent Consumption

    Total amount of anesthetic agents administered during surgery, recorded quantitatively (e.g., mg of intravenous agents and/or minimum alveolar concentration-hours of volatile anesthetics).

    From induction of anesthesia to the end of surgery

Secondary Outcomes (2)

  • Perioperative Hemodynamic Changes

    From induction of anesthesia until the end of surgery

  • Postoperative Vomiting

    Within 24 hours after surgery

Study Arms (3)

Follicular Phase Group

Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the follicular phase of the menstrual cycle based on postoperative serum progesterone levels. No experimental intervention will be applied. Intraoperative anesthetic consumption and postoperative nausea and vomiting will be recorded as part of routine perioperative management.

Luteal Phase Group

Female patients undergoing cholecystectomy under general anesthesia who are classified as being in the luteal phase of the menstrual cycle according to postoperative serum progesterone levels. No intervention beyond standard clinical care will be performed. Anesthetic drug consumption and postoperative nausea and vomiting outcomes will be documented.

Postmenopausal Group

Female patients undergoing cholecystectomy under general anesthesia who are postmenopausal. These patients will receive standard perioperative care. Intraoperative anesthetic requirements and postoperative nausea and vomiting will be assessed and compared with other hormonal status groups.

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study includes biologically female patients, as the research objective involves evaluation of menstrual cycle phases and menopausal status based on hormonal measurements.1
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of female patients aged 18-65 years with American Society of Anesthesiologists (ASA) physical status I-II-III who are scheduled for elective laparoscopic cholecystectomy under general anesthesia. Participants will be classified according to hormonal status (follicular phase, luteal phase, or postmenopausal) based on postoperative serum progesterone levels. All patients will receive standard perioperative care, and no experimental intervention will be applied.

You may qualify if:

  • Female patients aged 18 to 65 years
  • American Society of Anesthesiologists (ASA) physical status I-II-III
  • Scheduled for elective laparoscopic cholecystectomy under general anesthesia
  • Willing and able to provide written informed consent

You may not qualify if:

  • Age outside the specified range (younger than 18 or older than 65 years)
  • Male patients
  • American Society of Anesthesiologists (ASA) physical status ≥ IV
  • Severe systemic comorbidities (e.g., significant cardiovascular, hepatic, renal, or pulmonary disease)
  • Conversion from laparoscopic to open cholecystectomy
  • History of alcohol, drug, or substance abuse
  • Visual or hearing impairment interfering with study assessments
  • Current hormone replacement therapy
  • Use of oral contraceptives
  • Preoperative nausea or vomiting
  • History of severe postoperative nausea and vomiting
  • Neurological or psychiatric disorders affecting assessment reliability
  • Hemodynamic instability during surgery
  • Postoperative admission to intensive care unit
  • Acute cholecystitis at the time of surgery
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Ankara, 06170, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Officials

  • oya çimen, Specialist in Anesthesiology

    Ankara Etlik City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

oya Çimen, Specialist in Anesthesiology

CONTACT

Fethi Gültop, Specialist in Anesthesiology

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Specialist in Anesthesiology

Study Record Dates

First Submitted

February 28, 2026

First Posted

March 6, 2026

Study Start

March 7, 2026

Primary Completion

May 27, 2026

Study Completion

June 15, 2026

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be available upon reasonable request to the corresponding investigator, following publication of the study results, and subject to institutional and ethical approval.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 6 months after publication and available for up to 3 years.
Access Criteria
Data will be shared electronically after approval of a formal data request and signing of a data use agreement.

Locations